Abstract
Cholesterol ester storage disease (CESD) is a rare autosomal recessive lipid storage disorder associated with mutations of the gene encoding lysosomal acid lipase, manifestations of which include chronic liver disease and early atherosclerosis. Although normally presenting in childhood, severity is variable and the condition can occasionally remain undetected until middle age. Typical presentation is with asymptomatic hepatosplenomegaly and hyperlipidaemia, though the condition is probably underdiagnosed. Treatment is supportive and may include attention to cardiovascular risk factors. Phase I/II trials of enzyme replacement therapy are ongoing, but this approach remains experimental. We present the case of a 42-year-old woman diagnosed with CESD in childhood who ran an indolent course until re-presentation with cirrhotic hydrothorax. She underwent orthotopic liver transplantation but required re-transplantation for hepatic artery thrombosis. She remains well with excellent graft function 2 years later. Although atherosclerosis was apparent at assessment, and may have contributed to hepatic artery thrombosis, partial correction of the metabolic defect and restoration of liver function by transplantation together with ongoing medical therapy should permit reasonable survival over the longer term from both a liver and a vascular perspective. This is the first reported case of orthotopic liver transplantation for CESD in an adult, which was the only available option to improve survival. The case highlights the importance of monitoring patients with CESD through adulthood and suggests that liver replacement at a later stage may yet be indicated and remain of benefit.
Competing interests: None declared
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation 120:1640–1645
Anderson RA, Byrum RS, Coates PM et al (1994) Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci USA 91:2718–2722
Anderson RA, Rao N, Byrum RS et al (1993) In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3. Genomics 15:245–247
Anderson RA, Sando GN (1991) Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J Biol Chem 266:22479–22484
Arterburn JN, Lee WM, Wood RP et al (1991) Orthotopic liver transplantation for cholesteryl ester storage disease. J Clin Gastroenterol 13:482–485
Barber KM, Pioli SE, Blackwell JE et al (2007) Development of a UK score for patients with end-stage liver disease. Hepatology 46:510A
Chatrath H, Keilin S, Attar BM (2009) Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult. Dig Dis Sci 54:168–173
Du H, Cameron TL, Garger SJ et al (2008) Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. J Lipid Res 49:1646–1657
Elleder M, Chlumska A, Hyanek J et al (2000a) Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol 32:528–534
Elleder M, Chlumska A, Ledvinova J et al (2000b) Testis - a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma. Virchows Arch 436:82–87
Elleder M, Ledvinova J, Cieslar P et al (1990) Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process. Virchows Arch A 416:357–365
Enns G (2012) Initial human experience with sbc-102, a recombinant enzyme replacement therapy in adults with lysosomal acid lipase deficiency. Presented at the 8th Annual Lysosomal Disease Network (LDN) World Symposium
Ferry GD, Whisennand HH, Finegold MJ et al (1991) Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr 12:376–378
Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470
Leone L, Ippoliti PF, Antonicelli R (1991) Use of simvastatin plus cholestyramine in the treatment of lysosomal acid lipase deficiency. J Pediatr 119:1008–1009
Leone L, Ippoliti PF, Antonicelli R et al (1995) Treatment and liver transplantation for cholesterol ester storage disease. J Pediatr 127:509–510
Lewsey JD, Dawwas M, Copley LP et al (2006) Developing a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors. Transplantation 82:898–907
Maslen CL, Babcock D, Illingworth DR (1995) Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease. J Inherit Metab Dis 18:620–623
McCoy E, Yokoyama S (1991) Treatment of cholesteryl ester storage disease with combined cholestyramine and lovastatin. Ann NY Acad Sci 623:453–454
Muntoni S, Wiebusch H, Jansen-Rust M et al (2007) Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol 27:1866–1868
Natarajan P, Ray KK, Cannon CP (2010) High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol 55:1283–1299
Pisciotta L, Fresa R, Bellocchio A et al (2009) Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. Mol Genet Metab 97:143–148
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Frits Wijburg
Appendices
Synopsis
Regular follow-up of liver function in adults with cholesterol ester storage disease, an uncommon lipid storage disorder, is an important consideration as orthotopic liver transplantation may be required to maintain long-term survival.
Conflicts of Interest and Financial Disclosures
The authors would like to thank Synageva Biopharma Corporation for providing the chromatograms in Fig. 3.
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ambler, G.K. et al. (2012). Orthotopic Liver Transplantation in an Adult with Cholesterol Ester Storage Disease. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports - Case and Research Reports, 2012/5. JIMD Reports, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_155
Download citation
DOI: https://doi.org/10.1007/8904_2012_155
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-33432-0
Online ISBN: 978-3-642-33433-7
eBook Packages: MedicineMedicine (R0)